DABIGATRAN

作品数：34被引量：42H指数：4
导出分析报告
相关领域：医药卫生更多>>
相关机构：北京大学中国药科大学更多>>
相关期刊：《World Journal of Clinical Cases》《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》《Journal of Geriatric Cardiology》《Chinese Journal of Traumatology》更多>>
相关基金：国家重点基础研究发展计划更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 主题=RIVAROXABANx
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Effect of uninterrupted dabigatran or rivaroxaban on achieving ideal activated clotting time to heparin response during catheter ablation in patients with atrial fibrillation被引量：1
《Journal of Geriatric Cardiology》2022年第8期565-574,共10页Qian XIN Chuang ZHANG Yu-Jia WANG Jian LI Tao CHEN Shi-Xing LI Wei WANG Yu YANG Wen-Juan SONG Jin ZHOU Xiang-Min SHI 
supported by the Chinese PLA Special Research on Health Care (17BJZ08)
BACKGROUND Uninterrupted use of oral anticoagulants before atrial fibrillation(AF)ablation can reduce the incidence of perioperative thromboembolic events.However,the effect of new oral anticoagulants on activated clo...
关键词：PATIENTS HEPARIN DOSAGE 
Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis:What is the evidence?被引量：4
《World Journal of Hepatology》2022年第4期682-695,共14页Marco Biolato Mattia Paratore Luca Di Gialleonardo Giuseppe Marrone Antonio Grieco 
In recent years,the traditional concept that cirrhosis-related coagulopathy is an acquired bleeding disorder has evolved.Currently,it is known that in cirrhotic patients,the hemostatic system is rebalanced,which invol...
关键词：DABIGATRAN RIVAROXABAN APIXABAN EDOXABAN BLEEDING 
Dabigatran,rivaroxaban,and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation:An updated metaanalysis被引量：5
《World Journal of Cardiology》2021年第4期82-94,共13页Wei-Jia Li Paraschos Archontakis-Barakakis Leonidas Palaiodimos Dimitrios Kalaitzoglou Lazaros Tzelves Apostolos Manolopoulos Yu-Chiang Wang Stefanos Giannopoulos Robert Faillace Damianos G Kokkinidis 
BACKGROUND Most of the randomized clinical trials that led to the wide use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation(AF)originated from western countrie...
关键词：Novel oral anticoagulant Direct oral anticoagulant Atrial fibrillation Asian population DABIGATRAN RIVAROXABAN APIXABAN WARFARIN 
Laboratory Tests in Assessing the Bleeding Risk in Patients Receiving Direct Oral Anticoagulants (DOACs)
《World Journal of Cardiovascular Diseases》2018年第5期257-264,共8页Subhash Edupuganti Mary Wyrzykowski Elizabeth Wey Ming Xie 
Direct oral anticoagulants (DOACs)—apixaban, rivaroxaban and dabigatran have become the first line medications for patients with thromboembolism. However, DOAC therapy-associated bleeding complications remain the maj...
关键词：DIRECT Oral Anticoagulants Prothrombin TIME Partial THROMBOPLASTIN TIME APIXABAN RIVAROXABAN DABIGATRAN Bleeding Complications 
Gastrointestinal bleeding in patients on novel oral anticoagulants:Risk,prevention and management被引量：9
《World Journal of Gastroenterology》2017年第11期1954-1963,共10页Ka-Shing Cheung Wai K Leung 
Supported by the Li Shu Fan Medical Foundation Professorship(to Leung WK)
Novel oral anticoagulants(NOACs), which include direct thrombin inhibitor(dabigatran) and direct factor Xa inhibitors(rivaroxaban, apixaban and edoxaban), are gaining popularity in the prevention of embolic stroke in ...
关键词：WARFARIN ENDOSCOPY APIXABAN EDOXABAN Gastrointestinal bleeding DABIGATRAN RIVAROXABAN Novel anticoagulants 
Monitoring anticoagulant therapy with new oral agents被引量：1
《World Journal of Methodology》2015年第4期212-215,共4页Allan Ramos-Esquivel 
Thromboembolic disease is a major leading cause of mortality and morbidity in industrialized countries. Currently, the management of these patients is challenging due to the availability of new drugs with proven effic...
关键词：ANTICOAGULANT agents APIXABAN DABIGATRAN DRUG MONITORING RIVAROXABAN 
Bleeding and clotting in hereditary hemorrhagic telangiectasia被引量：1
《World Journal of Clinical Cases》2015年第4期330-337,共8页Christopher Dittus Michael Streiff Jack Ansell 
Hereditary hemorrhagic telangiectasia(HHT) is arelatively common inherited vascular disorder that was first described in 1864, and is notable for epistaxis, telangiectasia, and arterial venous malformations. While gen...
关键词：Anticoagulation Hereditary hemorrhagic TELANGIECTASIA Hemorrhage Thrombosis RIVAROXABAN APIXABAN DABIGATRAN WARFARIN 
Novel Therapeutic Options for the Treatment of Nonvalvular Atrial Fibrillation
《Pharmacology & Pharmacy》2014年第11期1070-1076,共7页Rupal Patel Mansukhani Lucio R. Volino 
Objective: To review the literature for the emerging oral anticoagulants, dabigatran, rivaroxaban, and apixaban currently available in the United States. Data Source: A literature review was performed in MEDLINE (1947...
关键词：ATRIAL FIBRILLATION DABIGATRAN RIVAROXABAN Apixiaban 
Clinical and pharmacological properties of new oral anticoagulants for the prevention of cerebral thromboembolism: Factor Xa and thrombin inhibitors
《World Journal of Neuroscience》2012年第1期7-14,共8页Yaroslav Winter Richard Dodel Alexei Korchounov Martin Grond Wolfgang H. Oertel Tobias Back 
Vitamin K antagonists, such as warfarin and phen-procoumon, are the first-line oral anticoagulants for primary and secondary prevention of cerebral embo-lism in patients with atrial fibrillation. Although vitamin K an...
关键词：THROMBIN INHIBITOR Factor Xa INHIBITOR DABIGATRAN RIVAROXABAN CEREBRAL Embolism Atrial Fibrillation 
Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy被引量：3
《World Journal of Cardiology》2011年第11期351-358,共8页Andrea Rubboli Cecilia Becattini Freek WA Verheugt 
Bleeding is the most important complication of oral anticoagulation (OAC) with vitamin K-antagonists. Whilst bleeding is unavoidably related to OAC, it may have a great impact on the prognosis of treated subjects by l...
关键词：Bleeding Oral ANTICOAGULATION VITAMIN K ANTAGONISTS DABIGATRAN APIXABAN RIVAROXABAN 
全选清除导出
共2页<12>
检索报告 对象比较 聚类工具 使用帮助 返回顶部